
Wendy's Board Rejects Peltz Bid, Activates Poison Pill Amid Turnaround Push
Wendy's rejected a $1.4 billion buyout offer from Nelson Peltz, deeming it undervalued, and activated a one-year poison pill to deter hostile takeovers. The chain reported better-than-expected third-quarter results despite ongoing sales declines, while CEO Bob Wright emphasized its 'Dave's Way' turnaround strategy.






